LOGIN  |  REGISTER
Surmodics

Recent Insider Transactions - Theseus Pharmaceuticals (NASDAQ: THRX)

Follow NASDAQ:THRX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ THRX Theseus Pharmaceuticals
Yi Kathy / director
02/14/2024
Sell
$4.03
99,634
$402K
0
NASDAQ THRX Theseus Pharmaceuticals
ORBIMED ADVISORS LLC / director, 10 percent owner:
02/14/2024
Sell
$4.05
650,600
$2.635M
0
NASDAQ THRX Theseus Pharmaceuticals
HAYDEN DONALD J JR / director
02/14/2024
Sell
$4.05
10,000
$41K
0
NASDAQ THRX Theseus Pharmaceuticals
GORDON CARL L / director, 10 percent owner:
02/14/2024
Sell
$4.05
650,600
$2.635M
0
NASDAQ THRX Theseus Pharmaceuticals
Dukes Iain D. / director
02/14/2024
Sell
$4.05
388,324
$1.573M
0
NASDAQ THRX Theseus Pharmaceuticals
Dukes Iain D. / director
02/14/2024
Sell
$0.32
344,344
$109K
0
NASDAQ THRX Theseus Pharmaceuticals
Dukes Iain D. / director
02/14/2024
Sell
$4.03
61,549
$248K
0
NASDAQ THRX Theseus Pharmaceuticals
Dahms Bradford D. / officer: President and CFO
02/14/2024
Sell
$4.05
8,150
$33K
0
NASDAQ THRX Theseus Pharmaceuticals
Dahms Bradford D. / officer: President and CFO
02/14/2024
Sell
$4.03
332,114
$1.340M
0
NASDAQ THRX Theseus Pharmaceuticals
Shakespeare William / officer: See Remarks
11/06/2023
Buy
$0.32
251,084
$80K
639,408
NASDAQ THRX Theseus Pharmaceuticals
Shakespeare William / officer: See Remarks
11/06/2023
Sell
$0.32
251,084
$80K
93,260
NASDAQ THRX Theseus Pharmaceuticals
GORDON CARL L / director, 10 percent owner:
07/17/2023
Buy
$3.05
328,482
$1.002M
17.06M
NASDAQ THRX Theseus Pharmaceuticals
GORDON CARL L / director, 10 percent owner:
07/17/2023
Buy
$3.05
151,450
$462K
650,600
NASDAQ THRX Theseus Pharmaceuticals
ORBIMED ADVISORS LLC / director, 10 percent owner:
07/17/2023
Buy
$3.05
328,482
$1.002M
17.06M
NASDAQ THRX Theseus Pharmaceuticals
ORBIMED ADVISORS LLC / director, 10 percent owner:
07/17/2023
Buy
$3.05
151,450
$462K
650,600
NASDAQ THRX Theseus Pharmaceuticals
Foresite Capital Management V, LLC / 10 percent owner
07/17/2023
Buy
$2.97
523,450
$1.555M
4.11M
NASDAQ THRX Theseus Pharmaceuticals
Foresite Capital Management V, LLC / 10 percent owner
07/17/2023
Buy
$2.97
176,550
$524K
1.39M
NASDAQ THRX Theseus Pharmaceuticals
Stein Steven H / director
06/13/2023
Buy
$9.61
19,500
$187K
19,500
NASDAQ THRX Theseus Pharmaceuticals
Yi Kathy / director
06/13/2023
Buy
$9.61
19,500
$187K
19,500
NASDAQ THRX Theseus Pharmaceuticals
HAYDEN DONALD J JR / director
06/13/2023
Buy
$9.61
19,500
$187K
19,500
NASDAQ THRX Theseus Pharmaceuticals
GORDON CARL L / director, 10 percent owner:
06/13/2023
Buy
$9.61
19,500
$187K
19,500
NASDAQ THRX Theseus Pharmaceuticals
Dukes Iain D. / director
06/13/2023
Buy
$9.61
19,500
$187K
19,500
NASDAQ THRX Theseus Pharmaceuticals
Shakespeare William / officer: See Remarks
02/17/2023
Buy
$11.42
127,500
$1.456M
127,500
NASDAQ THRX Theseus Pharmaceuticals
Rivera Victor / officer: Chief Scientific Officer
02/17/2023
Buy
$11.42
97,500
$1.113M
97,500
NASDAQ THRX Theseus Pharmaceuticals
Kerstein David / officer: Chief Medical Officer
02/17/2023
Buy
$11.42
105,000
$1.199M
105,000
NASDAQ THRX Theseus Pharmaceuticals
Dahms Bradford D. / officer: Chief Financial Officer
02/17/2023
Buy
$11.42
105,000
$1.199M
105,000
NASDAQ THRX Theseus Pharmaceuticals
CLACKSON TIMOTHY P / director, officer: President and CEO
02/17/2023
Buy
$11.42
273,750
$3.126M
273,750
NASDAQ THRX Theseus Pharmaceuticals
Foresite Capital Management V, LLC / director
12/29/2022
Buy
$5.00
250,000
$1.250M
3.59M
NASDAQ THRX Theseus Pharmaceuticals
Foresite Capital Management V, LLC / director
12/29/2022
Buy
$5.00
250,000
$1.250M
1.21M
NASDAQ THRX Theseus Pharmaceuticals
HAYDEN DONALD J JR / director
12/30/2022
Buy
$5.00
9,900
$49K
10,000
NASDAQ THRX Theseus Pharmaceuticals
HAYDEN DONALD J JR / director
12/29/2022
Buy
$5.00
100
$500
100
NASDAQ THRX Theseus Pharmaceuticals
Dahms Bradford D. / officer: Chief Financial Officer
11/30/2022
Buy
$6.66
1,502
$10K
6,142
NASDAQ THRX Theseus Pharmaceuticals
CLACKSON TIMOTHY P / officer: President and CEO
11/11/2022
Buy
$6.80
2,500
$17K
351,030
NASDAQ THRX Theseus Pharmaceuticals
GORDON CARL L / director
11/07/2022
Buy
$5.21
192,000
$1.000M
16.73M
NASDAQ THRX Theseus Pharmaceuticals
ORBIMED ADVISORS LLC / director
11/07/2022
Buy
$5.21
192,000
$1.000M
16.73M
NASDAQ THRX Theseus Pharmaceuticals
Dukes Iain D. / director, officer: Chairman
06/10/2022
Buy
$5.75
30,000
$173K
30,000
NASDAQ THRX Theseus Pharmaceuticals
Dukes Iain D. / director, officer: Chairman
06/10/2022
Buy
$5.75
15,000
$86K
15,000
NASDAQ THRX Theseus Pharmaceuticals
GORDON CARL L / director, 10 percent owner:
06/10/2022
Buy
$5.75
30,000
$173K
30,000

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous